A citation-based method for searching scientific literature

S Hussain, B B Kenigsberg, K Danahey, Y M Lee, P M Galecki, M J Ratain, P H O'Donnell. Clin Pharmacol Ther 2016
Times Cited: 14







List of co-cited articles
69 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics.
P H O'Donnell, A Bush, J Spitz, K Danahey, D Saner, S Das, N J Cox, M J Ratain. Clin Pharmacol Ther 2012
123
78

Adoption of a clinical pharmacogenomics implementation program during outpatient care--initial results of the University of Chicago "1,200 Patients Project".
Peter H O'Donnell, Keith Danahey, Michael Jacobs, Nisha R Wadhwa, Shennin Yuen, Angela Bush, Yasmin Sacro, Matthew J Sorrentino, Mark Siegler, William Harper,[...]. Am J Med Genet C Semin Med Genet 2014
81
78

Pharmacogenomics in the clinic.
Mary V Relling, William E Evans. Nature 2015
371
42

Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.
J M Pulley, J C Denny, J F Peterson, G R Bernard, C L Vnencak-Jones, A H Ramirez, J T Delaney, E Bowton, K Brothers, K Johnson,[...]. Clin Pharmacol Ther 2012
271
42


Implementing genomic medicine in the clinic: the future is here.
Teri A Manolio, Rex L Chisholm, Brad Ozenberger, Dan M Roden, Marc S Williams, Richard Wilson, David Bick, Erwin P Bottinger, Murray H Brilliant, Charis Eng,[...]. Genet Med 2013
335
42

Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.
Suzette J Bielinski, Janet E Olson, Jyotishman Pathak, Richard M Weinshilboum, Liewei Wang, Kelly J Lyke, Euijung Ryu, Paul V Targonski, Michael D Van Norstrand, Matthew A Hathcock,[...]. Mayo Clin Proc 2014
186
42

Development and use of active clinical decision support for preemptive pharmacogenomics.
Gillian C Bell, Kristine R Crews, Mark R Wilkinson, Cyrine E Haidar, J Kevin Hicks, Donald K Baker, Nancy M Kornegay, Wenjian Yang, Shane J Cross, Scott C Howard,[...]. J Am Med Inform Assoc 2014
129
42

Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
P H O'Donnell, N Wadhwa, K Danahey, B A Borden, S M Lee, J P Hall, C Klammer, S Hussain, M Siegler, M J Sorrentino,[...]. Clin Pharmacol Ther 2017
48
42

Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
E J Stanek, C L Sanders, K A Johansen Taber, M Khalid, A Patel, R R Verbrugge, B C Agatep, R E Aubert, R S Epstein, F W Frueh. Clin Pharmacol Ther 2012
271
35

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation.
A R Shuldiner, M V Relling, J F Peterson, J K Hicks, R R Freimuth, W Sadee, N L Pereira, D M Roden, J A Johnson, T E Klein,[...]. Clin Pharmacol Ther 2013
118
35

PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics.
James M Hoffman, Cyrine E Haidar, Mark R Wilkinson, Kristine R Crews, Donald K Baker, Nancy M Kornegay, Wenjian Yang, Ching-Hon Pui, Ulrike M Reiss, Aditya H Gaur,[...]. Am J Med Genet C Semin Med Genet 2014
153
35

The CLIPMERGE PGx Program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics.
O Gottesman, S A Scott, S B Ellis, C L Overby, A Ludtke, J-S Hulot, J Hall, K Chatani, K Myers, J L Kannry,[...]. Clin Pharmacol Ther 2013
99
35

Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
Henry M Dunnenberger, Kristine R Crews, James M Hoffman, Kelly E Caudle, Ulrich Broeckel, Scott C Howard, Robert J Hunkler, Teri E Klein, William E Evans, Mary V Relling. Annu Rev Pharmacol Toxicol 2015
262
35

Clinical pharmacogenetics implementation: approaches, successes, and challenges.
Kristin W Weitzel, Amanda R Elsey, Taimour Y Langaee, Benjamin Burkley, David R Nessl, Aniwaa Owusu Obeng, Benjamin J Staley, Hui-Jia Dong, Robert W Allan, J Felix Liu,[...]. Am J Med Genet C Semin Med Genet 2014
125
28

The IGNITE network: a model for genomic medicine implementation and research.
Kristin Wiisanen Weitzel, Madeline Alexander, Barbara A Bernhardt, Neil Calman, David J Carey, Larisa H Cavallari, Julie R Field, Diane Hauser, Heather A Junkins, Phillip A Levin,[...]. BMC Med Genomics 2016
129
28

A critical analysis of barriers to the clinical implementation of pharmacogenomics.
Ross A McKinnon, Michael B Ward, Michael J Sorich. Ther Clin Risk Manag 2007
38
28

Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.
R P McKillip, B A Borden, P Galecki, S A Ham, L Patrick-Miller, J P Hall, S Hussain, K Danahey, M Siegler, M J Sorrentino,[...]. Clin Pharmacol Ther 2017
18
28

Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems.
L J Rasmussen-Torvik, S C Stallings, A S Gordon, B Almoguera, M A Basford, S J Bielinski, A Brautbar, M H Brilliant, D S Carrell, J J Connolly,[...]. Clin Pharmacol Ther 2014
146
28

Implementation of a pharmacogenomics consult service to support the INGENIOUS trial.
M T Eadon, Z Desta, K D Levy, B S Decker, R C Pierson, V M Pratt, J T Callaghan, M B Rosenman, J S Carpenter, A M Holmes,[...]. Clin Pharmacol Ther 2016
33
28

Multidisciplinary model to implement pharmacogenomics at the point of care.
Pedro J Caraballo, Lucy S Hodge, Suzette J Bielinski, A Keith Stewart, Gianrico Farrugia, Cloann G Schultz, Carolyn R Rohrer-Vitek, Janet E Olson, Jennifer L St Sauver, Veronique L Roger,[...]. Genet Med 2017
48
28

Survey of US public attitudes toward pharmacogenetic testing.
S B Haga, J M O'Daniel, G M Tindall, I R Lipkus, R Agans. Pharmacogenomics J 2012
100
21

Electronic health record design and implementation for pharmacogenomics: a local perspective.
Josh F Peterson, Erica Bowton, Julie R Field, Marc Beller, Jennifer Mitchell, Jonathan Schildcrout, William Gregg, Kevin Johnson, Jim N Jirjis, Dan M Roden,[...]. Genet Med 2013
66
21

The Outlier in All of Us: Why Implementing Pharmacogenomics Could Matter for Everyone.
P H O'Donnell, K Danahey, M J Ratain. Clin Pharmacol Ther 2016
8
37

Design and implementation of a randomized controlled trial of genomic counseling for patients with chronic disease.
Kevin Sweet, Erynn S Gordon, Amy C Sturm, Tara J Schmidlen, Kandamurugu Manickam, Amanda Ewart Toland, Margaret A Keller, Catharine B Stack, J Felipe García-España, Mark Bellafante,[...]. J Pers Med 2014
17
21

Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.
Kelly E Caudle, Teri E Klein, James M Hoffman, Daniel J Muller, Michelle Whirl-Carrillo, Li Gong, Ellen M McDonagh, Katrin Sangkuhl, Caroline F Thorn, Matthias Schwab,[...]. Curr Drug Metab 2014
219
21

Institutional profile: University of Florida and Shands Hospital Personalized Medicine Program: clinical implementation of pharmacogenetics.
Julie A Johnson, Amanda R Elsey, Michael J Clare-Salzler, David Nessl, Michael Conlon, David R Nelson. Pharmacogenomics 2013
62
21

Pharmacogenetics: from bench to byte.
J J Swen, I Wilting, A L de Goede, L Grandia, H Mulder, D J Touw, A de Boer, J M H Conemans, T C G Egberts, O H Klungel,[...]. Clin Pharmacol Ther 2008
154
21

Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs.
Amy L Kaufman, Jared Spitz, Michael Jacobs, Matthew Sorrentino, Shennin Yuen, Keith Danahey, Donald Saner, Teri E Klein, Russ B Altman, Mark J Ratain,[...]. Mayo Clin Proc 2015
29
21

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.
C H van der Wouden, A Cambon-Thomsen, E Cecchin, K C Cheung, C L Dávila-Fajardo, V H Deneer, V Dolžan, M Ingelman-Sundberg, S Jönsson, M O Karlsson,[...]. Clin Pharmacol Ther 2017
138
21

Simplifying the use of pharmacogenomics in clinical practice: Building the genomic prescribing system.
Keith Danahey, Brittany A Borden, Brian Furner, Patrick Yukman, Sheena Hussain, Donald Saner, Samuel L Volchenboum, Mark J Ratain, Peter H O'Donnell. J Biomed Inform 2017
22
21

Consumers' views of pharmacogenetics--A qualitative study.
Catherine A Haddy, Helena M Ward, Manya T Angley, Ross A McKinnon. Res Social Adm Pharm 2010
34
14

Clinician Perspectives on Using Pharmacogenomics in Clinical Practice.
Kim M Unertl, Habiba Jaffa, Julie R Field, Lisa Price, Josh F Peterson. Per Med 2015
41
14

Opinions, hopes and concerns regarding pharmacogenomics: a comparison of healthy individuals, heart failure patients and heart transplant recipients.
K Lachance, S Korol, E O'Meara, A Ducharme, N Racine, M Liszkowski, J L Rouleau, G B Pelletier, M Carrier, M White,[...]. Pharmacogenomics J 2015
7
28

Patients' and physicians' perspectives on pharmacogenetic testing.
Anja Rogausch, Daniela Prause, Anne Schallenberg, Jürgen Brockmöller, Wolfgang Himmel. Pharmacogenomics 2006
81
14

Assessing patient readiness for the clinical adoption of personalized medicine.
A M Issa, W Tufail, J Hutchinson, J Tenorio, M Poonam Baliga. Public Health Genomics 2009
40
14


Public perspectives about pharmacogenetic testing and managing ancillary findings.
Susanne B Haga, Genevieve Tindall, Julianne M O'Daniel. Genet Test Mol Biomarkers 2012
40
14

An overview of 19 instruments assessing the doctor-patient relationship: different models or concepts are used.
Rhona M Eveleigh, Esther Muskens, Hiske van Ravesteijn, Inge van Dijk, Eric van Rijswijk, Peter Lucassen. J Clin Epidemiol 2012
61
14


Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
Kelly E Caudle, Henry M Dunnenberger, Robert R Freimuth, Josh F Peterson, Jonathan D Burlison, Michelle Whirl-Carrillo, Stuart A Scott, Heidi L Rehm, Marc S Williams, Teri E Klein,[...]. Genet Med 2017
226
14

Emerging roles for pharmacists in clinical implementation of pharmacogenomics.
Aniwaa Owusu-Obeng, Kristin W Weitzel, Randy C Hatton, Benjamin J Staley, Jennifer Ashton, Rhonda M Cooper-Dehoff, Julie A Johnson. Pharmacotherapy 2014
79
14

Physician response to implementation of genotype-tailored antiplatelet therapy.
J F Peterson, J R Field, K M Unertl, J S Schildcrout, D C Johnson, Y Shi, I Danciu, J H Cleator, J M Pulley, J A McPherson,[...]. Clin Pharmacol Ther 2016
36
14

Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping.
J S Schildcrout, J C Denny, E Bowton, W Gregg, J M Pulley, M A Basford, J D Cowan, H Xu, A H Ramirez, D C Crawford,[...]. Clin Pharmacol Ther 2012
125
14

A prognostic model based on readily available clinical data enriched a pre-emptive pharmacogenetic testing program.
Jonathan S Schildcrout, Yaping Shi, Ioana Danciu, Erica Bowton, Julie R Field, Jill M Pulley, Melissa A Basford, William Gregg, James D Cowan, Frank E Harrell,[...]. J Clin Epidemiol 2016
12
16


Views on personalized medicine: do the attitudes of African American and white prescription drug consumers differ?
M De Marco, S Cykert, N Coad, K Doost, J Schaal, B White, D Young, M R Isler, G Corbie-Smith. Public Health Genomics 2010
14
14


Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial.
S L Charland, B C Agatep, V Herrera, B Schrader, F W Frueh, M Ryvkin, J Shabbeer, J J Devlin, H R Superko, E J Stanek. Pharmacogenomics J 2014
38
14



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.